---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-196481"
form_type: "8-K"
ticker: "VNDA"
cik: "0001347178"
company_name: "Vanda Pharmaceuticals Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:45:03.543379+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Vanda amends Rights Agreement to clarify definitions of Acting in Concert and Beneficial Owner

## Summary
- Entered Amendment No. 2 to Rights Agreement on August 7, 2024 with Equiniti Trust Company as rights agent.
- Amendment makes punctuation corrections to the definition of 'Acquiring Person'.
- Amends and restates definitions of 'Acting in Concert' and 'Beneficial Owner' for clarifying changes.

## SEC filing metadata
- accession: 0001193125-24-196481
- form_type: 8-K
- ticker: VNDA
- cik: 0001347178
- company_name: Vanda Pharmaceuticals Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347178/000119312524196481/0001193125-24-196481-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347178/000119312524196481/d862724d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-196481
- JSON: https://secwatch.observer/filing/0001193125-24-196481.json
- Plain text: https://secwatch.observer/filing/0001193125-24-196481.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.